Teva and Prestige Biopharma enter license agreement for Tuznue commercialization in Europe
Tuznue is a biosimilar of Herceptin (trastuzumab), developed to offer a more cost-effective therapeutic alternative for patients
Tuznue is a biosimilar of Herceptin (trastuzumab), developed to offer a more cost-effective therapeutic alternative for patients
Advancing clinical pharmacokinetic prediction beyond non-human primate models
New EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNA
Find out why millions of cases of hepatitis B and C are going undiagnosed and how clinical labs could play an important role in getting more people tested and treated
New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helping clinicians distinguish dengue from other acute fever-causing illnesses
Researchers save time, effort, and precious samples with round-the-lab access to ultra-pure water with precise volume control
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing
The EFOX system delivers highly sensitive, full-scan data that helps labs detect persistent compounds faster, with more confidence, and in compliance with tightening regulations
How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics
Guest editorial features key takeaways from Balancing the Future Podcast, Season 1, Episode 3, by METTLER TOLEDO
Collaboration will evaluate the impact of the OMED solution on the digestive health and quality of life of participants in a workplace setting
Read Ocean Optics’ guest editorial exploring how these three key pillars are helping clinicians make faster, more informed treatment decisions at the bedside
Discover how advanced imaging technology is enabling continuous drug safety monitoring in liver organoids
In this guest editorial from Euroimmun, learn how immunoassay analyes support optimization of drug levels within the therapeutic window
Activace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epigenome that can be scaled to the study of large patient cohorts
Agreement will expand the availability of Gencurix’s in vitro diagnostic (IVD) assays using Droplet Digital™ PCR (ddPCR™) for clinical testing of critical oncology biomarkers across Europe
Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date
Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
Researchers say the work demonstrates that precise gene editing can prevent infection by disrupting a pig protein the virus relies on to make copies of itself within the cells of the pig
Communication, engagement and promotion in a modern world — Terry Taylor, past president of The New Zealand Institute of Medical Laboratory Science (Inc.) shares his views in this guest editorial
Guest editorial by Susan Dawson, retired laboratory leader and founder of Accomplish More Consulting Services (AMCS)